JAMA Network Home
Sign In
Research Letter

US Food and Drug Administration Competitive Generic Therapy Approvals and Drug Competition

JAMA Internal Medicine 10.1001/jamainternmed.2025.6072

November 17, 2025 at 11:00 AM EST

Read the full article

This cross-sectional study examines the dynamics of competitive generic therapy drug pricing and volume.

Corresponding Author: Harinder Singh Chahal, PharmD, MSc, US Food and Drug Administration, 10903 New Hampshire Ave, Bldg 32, #4220, Silver Spring, MD 20993 (harinder.chahal@fda.hhs.gov).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.6072?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111725

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks